A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer

Rajesh Sehgal, Barry C. Lembersky, Kiran K. Rajasenan, Theodore L. Crandall, Edward Balaban, Richard A. Pinkerton, Patrick Kane, Amy Schmotzer, Herbert Zeh, Douglas M. Potter, Ramesh K. Ramanathan

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Fingerprint

Dive into the research topics of 'A phase I/II study of capecitabine given on a week on/week off schedule combined with bevacizumab and oxaliplatin for patients with untreated advanced colorectal cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences